Dr. Diehl is a Commercialization Officer in the Office of Research and Technical Applications (ORTA)/Medical Technology Transfer, United States Army Medical Research and Development Command (USAMRDC). His roles include technology ideation, evaluation, protection, and commercialization with a focus on business start-ups and an emphasis on therapeutics, vaccines, and diagnostics. Dr. Diehl has more than 25 years of experience evaluating and developing life science technologies. He has held two faculty positions – Assistant Professor of Natural and Health Sciences at Barry University and Research Assistant Professor at the Northwestern University School of Medicine. He was subsequently hired as a Senior Scientist in the Diagnostic Division of Abbott Laboratories and contributed to the validation and launch or re-launch of seven cancer diagnostic tests on three instrument platforms. He moved on to entrepreneurial roles at several start-ups and academic institutions where he participated in R&D, investment, licensing, and business and intellectual property development efforts. He founded the Diehl Group LLC, a life science consulting firm, which became Pathway Biotechnology in 2018. He holds a B.S. in Biology from the Pennsylvania State University, a Ph.D. in Physiology and Biophysics from the University of Iowa.